CN110818732B - 基于bodipy的高效实时生物硫醇荧光检测探针 - Google Patents
基于bodipy的高效实时生物硫醇荧光检测探针 Download PDFInfo
- Publication number
- CN110818732B CN110818732B CN201911083391.7A CN201911083391A CN110818732B CN 110818732 B CN110818732 B CN 110818732B CN 201911083391 A CN201911083391 A CN 201911083391A CN 110818732 B CN110818732 B CN 110818732B
- Authority
- CN
- China
- Prior art keywords
- dye
- probe
- bod
- synthesis
- dichloromethane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000523 sample Substances 0.000 title claims abstract description 74
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 title abstract description 4
- 238000001917 fluorescence detection Methods 0.000 title description 5
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 48
- 238000001514 detection method Methods 0.000 claims abstract description 30
- 210000003463 organelle Anatomy 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 210000004027 cell Anatomy 0.000 claims abstract description 6
- 238000003384 imaging method Methods 0.000 claims abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 118
- 239000000975 dye Substances 0.000 claims description 63
- 230000015572 biosynthetic process Effects 0.000 claims description 62
- 238000003786 synthesis reaction Methods 0.000 claims description 62
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 238000006243 chemical reaction Methods 0.000 claims description 32
- 239000012044 organic layer Substances 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 22
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 20
- 239000012043 crude product Substances 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 18
- 238000010828 elution Methods 0.000 claims description 16
- 239000003960 organic solvent Substances 0.000 claims description 16
- 238000010898 silica gel chromatography Methods 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 238000004821 distillation Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 8
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 8
- 125000003396 thiol group Chemical class [H]S* 0.000 claims description 8
- 238000001308 synthesis method Methods 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 210000002472 endoplasmic reticulum Anatomy 0.000 claims description 6
- 239000012046 mixed solvent Substances 0.000 claims description 6
- 239000012074 organic phase Substances 0.000 claims description 6
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 6
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 6
- 229960005055 sodium ascorbate Drugs 0.000 claims description 6
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 6
- 230000008685 targeting Effects 0.000 claims description 6
- -1 (4-azidobutyl) triphenyl phosphine bromide Chemical compound 0.000 claims description 5
- 210000003470 mitochondria Anatomy 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 230000002194 synthesizing effect Effects 0.000 claims description 5
- 150000001299 aldehydes Chemical class 0.000 claims description 4
- 239000012295 chemical reaction liquid Substances 0.000 claims description 4
- 239000007790 solid phase Substances 0.000 claims description 4
- YMORVLBMLSBFQJ-UHFFFAOYSA-N 1-azido-3-chloropropane Chemical compound ClCCCN=[N+]=[N-] YMORVLBMLSBFQJ-UHFFFAOYSA-N 0.000 claims description 3
- NBEFMISJJNGCIZ-UHFFFAOYSA-N 3,5-dimethylbenzaldehyde Chemical compound CC1=CC(C)=CC(C=O)=C1 NBEFMISJJNGCIZ-UHFFFAOYSA-N 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 229960000583 acetic acid Drugs 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 239000012362 glacial acetic acid Substances 0.000 claims description 3
- 238000005286 illumination Methods 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 229910052724 xenon Inorganic materials 0.000 claims description 3
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 claims description 3
- HSJKGGMUJITCBW-UHFFFAOYSA-N 3-hydroxybutanal Chemical compound CC(O)CC=O HSJKGGMUJITCBW-UHFFFAOYSA-N 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 1
- 238000002390 rotary evaporation Methods 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 abstract description 46
- 230000004044 response Effects 0.000 abstract description 22
- 238000001228 spectrum Methods 0.000 abstract description 13
- 230000008901 benefit Effects 0.000 abstract description 8
- 230000035945 sensitivity Effects 0.000 abstract description 8
- 238000012360 testing method Methods 0.000 abstract description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 82
- 229960003180 glutathione Drugs 0.000 description 41
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 38
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 238000012512 characterization method Methods 0.000 description 17
- 238000005160 1H NMR spectroscopy Methods 0.000 description 14
- 238000002189 fluorescence spectrum Methods 0.000 description 13
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Substances C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 11
- 125000001309 chloro group Chemical group Cl* 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 8
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 8
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 7
- 239000003480 eluent Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000001819 mass spectrum Methods 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 108010024636 Glutathione Proteins 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000003208 petroleum Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- 238000004252 FT/ICR mass spectrometry Methods 0.000 description 5
- 125000003172 aldehyde group Chemical group 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 238000006073 displacement reaction Methods 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- 238000006845 Michael addition reaction Methods 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229960000956 coumarin Drugs 0.000 description 4
- 235000001671 coumarin Nutrition 0.000 description 4
- 239000008055 phosphate buffer solution Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000012921 fluorescence analysis Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000006862 quantum yield reaction Methods 0.000 description 3
- 238000011897 real-time detection Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- MFFMQGGZCLEMCI-UHFFFAOYSA-N 2,4-dimethyl-1h-pyrrole Chemical compound CC1=CNC(C)=C1 MFFMQGGZCLEMCI-UHFFFAOYSA-N 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 2
- ORMHZBNNECIKOH-UHFFFAOYSA-N 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde Chemical compound CC(C)(O)CCCC1=CCC(C=O)CC1 ORMHZBNNECIKOH-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- PAPNRQCYSFBWDI-UHFFFAOYSA-N DMP Natural products CC1=CC=C(C)N1 PAPNRQCYSFBWDI-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 150000003934 aromatic aldehydes Chemical group 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- XJHABGPPCLHLLV-UHFFFAOYSA-N benzo[de]isoquinoline-1,3-dione Chemical compound C1=CC(C(=O)NC2=O)=C3C2=CC=CC3=C1 XJHABGPPCLHLLV-UHFFFAOYSA-N 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000010413 mother solution Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- YTGSYRVSBPFKMQ-UHFFFAOYSA-N 2,2,2-tribromoacetaldehyde Chemical compound BrC(Br)(Br)C=O YTGSYRVSBPFKMQ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000012625 DNA intercalator Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010083687 Ion Pumps Proteins 0.000 description 1
- 125000000415 L-cysteinyl group Chemical group O=C([*])[C@@](N([H])[H])([H])C([H])([H])S[H] 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 238000013494 PH determination Methods 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 239000012490 blank solution Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 150000004696 coordination complex Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002596 lactones Chemical group 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 238000007248 oxidative elimination reaction Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- YORCIIVHUBAYBQ-UHFFFAOYSA-N propargyl bromide Chemical compound BrCC#C YORCIIVHUBAYBQ-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000001022 rhodamine dye Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000000954 titration curve Methods 0.000 description 1
- SPOMEWBVWWDQBC-UHFFFAOYSA-K tripotassium;dihydrogen phosphate;hydrogen phosphate Chemical compound [K+].[K+].[K+].OP(O)([O-])=O.OP([O-])([O-])=O SPOMEWBVWWDQBC-UHFFFAOYSA-K 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- LEAHFJQFYSDGGP-UHFFFAOYSA-K trisodium;dihydrogen phosphate;hydrogen phosphate Chemical compound [Na+].[Na+].[Na+].OP(O)([O-])=O.OP([O-])([O-])=O LEAHFJQFYSDGGP-UHFFFAOYSA-K 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/022—Boron compounds without C-boron linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6596—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having atoms other than oxygen, sulfur, selenium, tellurium, nitrogen or phosphorus as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
- C09K2211/1055—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with other heteroatoms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明公开了一种快速实时检测生物硫醇的比率型荧光探针,还公开了该探针的制备方法及其应用。光谱测试结果表明,该探针对生物硫醇具有比率型响应、高选择性、高灵敏度、响应时间快以及斯托克斯位移大等优点。该探针对生物硫醇的响应时间与大多数生物硫醇荧光探针相比具有实时快速的特点,且能用于细胞以及细胞器的靶向成像,这些优点可使本发明的探针满足高通量检测生物硫醇的需求。
Description
技术领域
本发明涉及一种基于BODIPY的高效实时生物硫醇荧光检测探针,还涉及该探针的制备 方法及应用,属于有机小分子荧光探针技术领域。
背景技术
随着生命科学研究的不断深入和发展,越来越多的精密生物分析手段应用到研究微观的 生物体系来获取有效的研究现象和结果。例如放射性同位素标记法、高倍显微观察、电化学 分析方法等等,但由于自身固有的缺陷,在实际应用中这些技术的局限性越来越突出。随着 荧光分析检测技术的不断发展,荧光染料在DNA杂交测试、基因重组检测、肿瘤细胞早期 诊断、免疫检测和各种生物活性离子以及生物体内各种自由基的分析检测等方面得到广泛应 用。可以说,荧光分析技术以其较高的检测灵敏度、较好的选择性、易操作、低成本等优点, 已在生物分析领域发挥着不可替代的作用。荧光分析技术最关键部分就是荧光染料,荧光染 料性能的优劣直接影响探针检测的灵敏性及准确性。因此研究适用于荧光标识的荧光染料及 开发优秀的荧光探针将对生物分析技术及生命科学研究的发展至关重要。
由于染料自身性能的多样性,导致不同染料在生物检测分析过程中表现出很大的差异, 并不是所有的荧光染料都能用作荧光探针的荧光团而应用在生化分析与生物检测领域。现有 技术中已成功应用的荧光染料有:香豆素类荧光染料,具有光稳定性较好、Stokes位移大、 油溶性好、分子体积比较小等诸多优点,香豆素染料性能上的主要缺点是吸收发射波长过短, 大多数都是蓝色的荧光,并且香豆素染料的不饱和内酯结构在稀碱液中会发生水解反应,对 其的应用有很大的限制。萘酰亚胺类染料,能够与DNA相互作用,是一种优秀的DNA嵌入 剂,量子产率较高,光稳定性好,是很有用的生物标记物。但是萘酰亚胺类染料的颜色较浅 并且摩尔消光系数较低,对其应用有一定的限制。荧光素和罗丹明类染料,此类荧光染料的 特点是水溶性好,光稳定性较好,吸收发射波长相对较长,量子产率高;但由于染料中氨基 和羟基的存在,使得该染料对pH值比较敏感,在应用作离子或者生物分子探针时,对工作 环境酸碱性有一定的要求。菁染料,目前已成功引用于检测DNA、核苷酸、蛋白质等荧光探 针,但是此类染料的缺点是光稳定性差,多甲川结构容易在光照下发生氧化断裂,导致染料 分解,另外多甲川结构也导致染料容易发生聚积,影响了该染料在应用方面的推广。
然而,氟硼二吡咯甲川(BODIPY)类染料,是一种性能优越的染料,因其良好的光化学稳定性、高摩尔消光系数、高荧光量子产率、分子结构易于修饰、荧光光谱半峰宽窄、对溶剂极性和pH的耐受性好等众多优点而被广泛应用于光电器件、生物标记以及荧光探针等领域。
生物硫醇,主要包括半胱氨酸(Cys)、高半胱氨酸(Hcy)和谷胱甘肽(GSH),它们在生物体系中扮演着至关重要的作用。生物体系中硫醇物质的新陈代谢与运输和一系列重要的 酶和蛋白质密切相关。细胞内硫醇水平异常与许多疾病都有关联,如白细胞损失、牛皮癣、 肝损伤和艾滋病等。因此设计合成对生物硫醇具有高选择性、高灵敏度和实时快速响应的荧 光探针具有非常重要的意义。生物硫醇与其他氨基酸相比最为显著的特点是含有强亲核性的 巯基。目前报道的生物硫醇荧光探针,主要基于迈克尔加成反应、金属络合物置换、与醛环 化加成以及二硫键还原等机理。其中基于迈克尔加成反应的硫醇探针由于其灵敏度高,可在 近生理条件下对硫醇进行检测等优点受到了广泛的关注。但该类探针大部分都存在着对硫醇 响应时间较长等问题,一般从几分钟到几个小时不等,不利于对硫醇物质的实时定量检测。 只有极少数探针对生物硫醇响应时间短,可用于生物硫醇的快速实时检测,但这些探针基本 上是(关/开)OFF/ON型荧光探针。OFF/ON型荧光探针的信号表达容易受到外界因素的干 扰而影响检测结果,比率型荧光探针由于以两个不同波长处的荧光强度比值作为自身校准参 数,可以有效弥补OFF/ON型荧光探针的不足之处。因此设计和开发可以用于快速实时检测 硫醇物质的比率型荧光探针具有很重要的现实意义。
现有的实时响应型生物硫醇比率型荧光探针存在的主要问题是没有细胞器靶向功能且斯 托克斯位移小,导致严重的荧光自淬灭和瑞利散射而引起检测误差。
发明内容
为了解决上述现有技术中存在的问题,本发明的一个目的在于提供一种快速实时检测生 物硫醇的比率型荧光探针,所述探针的结构式为如下式(I)所示化合物:
其中R1选自氢、式(III)、式(IV);R2或R3选自式(II);R4或R5选自甲基;
所述式(II)如下:
其中R4或R5选自氢;
所述式(III)如下:
所述式(IV)如下:
(BOD-Cl),所述R7为Cl。
优选地,所述的探针,其结构选自如下:
(BOD-PPh3),或
所述R7为Cl。
本发明的另一目的在于提供一种快速实时检测生物硫醇的比率型荧光探针的制备方法, 包括如下步骤:
(1)染料氟硼二吡咯甲川-简双(BOD-JS)、氟硼二吡咯甲川-炔双(BOD-QS)和氟硼二吡咯甲川-叠双(BOD-DS)的合成;
(2)固相光化学合成α-甲酰化BODIPY衍生物;
(3)细胞器靶向荧光染料合成;
其中,所述步骤(1)的合成方法包括:向无水N,N-二甲基甲酰胺(DMF)中加入中间染料氟硼二吡咯甲川-简(BOD-J)、氟硼二吡咯甲川-炔(BOD-Q)或氟硼二吡咯甲川-叠(BOD-D),以及3,5-二甲基苯甲醛,除氧后,加入哌啶和冰醋酸,室温搅拌后,置于微波反 应器中反应。待反应结束后,将冷却的反应液倾入二氯甲烷中,并分别用饱和食盐水和水洗涤数次,随后用无水硫酸镁干燥有机层,过滤后滤液经减压蒸馏除去多余的有机溶剂,所得粗产物用少量二氯甲烷溶解后经硅胶柱层析,梯度洗脱进行分离提纯,最后得到BOD-JS、BOD-QS或BOD-DS粉末;
所述步骤(2)包括,染料氟硼二吡咯甲川-简醛(BOD-JQ)、氟硼二吡咯甲川-炔醛(BOD-QQ) 和/或染料氟硼二吡咯甲川-叠醛(BOD-DQ)的合成;
所述步骤(3)中所述细胞器为线粒体或内质网。
优选地,上述方法中所述BOD-JQ、BOD-QQ或BOD-DQ的合成方法包括:将染料BOD-JS、 BOD-QS或BOD-DS溶解于二氯甲烷中,然后加入50-500目硅胶,经减压旋转蒸发溶剂,并将混合物置于氙气灯下方处光照,可观察到混合物由墨绿色变为紫黑色,待混合物冷却至室 温后,用二氯甲烷萃取数次,合并有机相,经减压蒸馏除去多余有机溶剂,所得粗产物用少 量二氯甲烷溶解后经硅胶柱层析,梯度洗脱进行分离提纯,最后得到粉末。
优选地,上述方法还包括中间染料的合成,所述中间染料为氟硼二吡咯甲川-简(BOD-J)、 中间体炔醛(QQ)、氟硼二吡咯甲川-炔(BOD-Q)、中间体溴醛(XQ)、中间体叠醛(DQ) 和氟硼二吡咯甲川-叠(BOD-D)。
优选地,上述方法中所述细胞器靶向荧光染料合成步骤包括:
在氮气保护下,将BOD-QQ以及(4-叠氮丁基)三苯基溴化膦溶于混合溶剂中,随后加 入五水合硫酸铜和抗坏血酸钠,用锡箔纸包住避光,室温搅拌反应,待反应结束后,加入水, 剧烈震荡,用二氯甲烷萃取,收集有机层,并将有机层用饱和食盐水和水依次洗涤数次,随 后用无水硫酸钠干燥有机层,过滤后滤液经减压蒸馏除去多余的有机溶剂,所得粗产物用少 量二氯甲烷溶解后经硅胶柱层析,梯度洗脱进行分离提纯,最后得到粉末;所述细胞器为线 粒体。
优选地,上述方法中所述细胞器靶向荧光染料合成步骤包括:
在氮气保护下,将BOD-QQ以及1-叠氮-3-氯丙烷溶于混合溶剂中,随后加入五水合硫酸 铜和抗坏血酸钠,用锡箔纸包住避光,室温搅拌反应;随后将反应置于冰浴中,缓慢滴加三 乙胺和三氟化硼乙醚,继续搅拌;待反应结束后,加入水,剧烈震荡,用二氯甲烷萃取,收 集有机层,并将有机层用饱和食盐水和水依次洗涤数次;随后用无水硫酸钠干燥有机层,过 滤后滤液经减压蒸馏除去多余的有机溶剂;所得粗产物用少量二氯甲烷溶解后经硅胶柱层析, 梯度洗脱进行分离提纯,最后得到粉末。
本发明的另一目的在于提供一种快速实时检测生物硫醇的比率型荧光探针的应用,所述 应用选自如下(1)-(4)之一:
(1)在生物硫醇检测中的应用,所述生物硫醇优选为半胱氨酸(Cys)、高半胱氨酸(Hcy) 和/或谷胱甘肽(GSH);
(2)在细胞成像中的应用;
(3)在制备生物硫醇检测或细胞成像的试剂或试剂盒中的应用;
(4)在细胞器检测中的应用。
优选地,上述应用中所述生物硫醇检测是在偏碱性条件下进行,优选pH为7.2-8.0,更优 选pH为7.4。
优选地,上述应用中所述细胞器为内质网和/或线粒体。
与现有技术相比,本发明具有以下有益效果:
本发明开发了一种快速实时检测生物硫醇的比率型荧光探针。光谱测试结果表明,该探 针对生物硫醇具有比率型响应、高选择性、高灵敏度、响应时间快以及斯托克斯位移大等优 点。探针对生物硫醇的响应时间与大多数生物硫醇荧光探针相比具有实时快速的特点,这一 优点可使其满足高通量检测生物硫醇的需求。此外,与为数不多的几例实时响应生物硫醇荧 光探针(OFF/ON型或(开/关)ON/OFF型)相比,探针的比率型响应机制可以有效弥补OFF/ON 型或ON/OFF型荧光探针的信号表达容易受到外界因素的干扰而影响检测结果的缺点。与现 有技术已报道的实时响应型比率型荧光探针相比,本探针具有细胞器靶向功能,如线粒体靶 向:体外线粒体膜电位180~200mV时,内侧带负电,在活细胞和机体内略低,为130~150mV, 利用亲脂阳离子进行药物递送,其中研究最为成功的是三苯基膦,三苯基膦含有三个苯环可 增大分子表面积,并形成离域正电荷,可穿过线粒体双层疏水膜;又如内质网靶向:氯原子 官能团的存在实现了其与内质网上氯离子泵的特异性结合,从而完成了对内质网的定位,且 斯托克斯位移更大,本发明的探针的斯托克斯位移也达到了52nm,比目前报道的最大斯托克 斯位移提高了约13nm。同时该探针溶液在体外遇到生物硫醇后颜色由粉红色变为淡黄色,可 用于直观裸眼检测。这也为设计合成比率型生物硫醇荧光探针提供了新的思路。
附图说明
图1,探针合成路线图,具体为醛基BODIPY的合成。
图2,BOD-J合成路线。
图3,BOD-JS合成路线。
图4,QQ合成路线。
图5,BOD-Q合成路线。
图6,BOD-QS合成路线。
图7,XQ合成路线。
图8,DQ合成路线。
图9,BOD-D合成路线。
图10,BOD-DS合成路线。
图11,BOD-JQ合成路线。
图12,BOD-JQ1H核磁谱图(CDCl3)。
图13,BOD-JQ13C核磁谱图(CDCl3)。
图14,BOD-JQ高分辨质谱图。
图15,BOD-QQ合成路线。
图16,BOD-QQ1H核磁谱图(CDCl3)。
图17,BOD-QQ13C核磁谱图(CDCl3)。
图18,BOD-QQ高分辨质谱图。
图19,BOD-DQ合成路线。
图20,BOD-DQ1H核磁谱图(CDCl3)。
图21,BOD-DQ13C核磁谱图(CDCl3)。
图22,BOD-DQ高分辨质谱图。
图23,BOD-PPh3合成路线。
图24,BOD-PPh31H核磁谱图(DMSO-d6)。
图25,BOD-PPh313C核磁谱图(DMSO-d6)。
图26,BOD-PPh3高分辨质谱图。
图27,BOD-Cl合成路线。
图28,BOD-Cl1H核磁谱图(CDCl3)。
图29,BOD-Cl13C核磁谱图(CDCl3)。
图30,BOD-Cl高分辨质谱图。
图31,pH对BOD-JQ(5μM)加入500μM GSH前后荧光强度比值(I544nm/I596nm)的 影响,R为加入GSH后I544nm/I596nm的比值,R0为加入GSH前I544nm/I596nm的比值(λex=510 nm)。
图32,pH对BOD-JQ(5μM)加入500μM GSH前后荧光强度比值(I544nm/I596nm) 相对值的影响,R为加入GSH后I544nm/I596nm的比值,R0为加入GSH前I544nm/I596nm的比 值(λex=510nm)。
图33,探针分子BOD-JQ(5μM)随着GSH溶液的加入(0~1000μM)(a)紫外- 可见吸收光谱和(b)荧光发射光谱变化图(λex=510nm)。
图34,(a)探针分子BOD-JQ(5μM)随着GSH溶液的加入(0~1000μM)其荧光 强度比值(I544nm/I596nm)与GSH浓度关系曲线(b)探针分子BOD-JQ(5μM)荧光强度 比值(I544nm/I596nm)对不同GSH浓度(0~70μM)的拟合曲线(λex=510nm)。
图35,探针BOD-JQ(5μM)在不同物质(500μM)存在时的荧光强度比值(I544nm /I596nm)(λex=510nm)。
图36,探针BOD-JQ(5μM)在不同物质(500μM)存在时对GSH响应的荧光强度 比值(I544nm/I596nm)(λex=510nm)。
图37,基于醛基为识别基团的探针与Cys/Hcy的反应。
图38,探针BOD-JQ(5μM)与Cys、Hcy和GSH响应的荧光光谱图(500μM,λex=510nm)。
具体实施方式
以下通过具体实施例对本发明作进一步详细说明,以使本领域技术人员能够更好地理解 本发明并予以实施,但实施例并不作为本发明的限定。
以下实施例中所使用的实验方法如无特殊说明,均为常规方法。所用的材料、试剂等, 如无特殊说明,均可从商业途径得到。
实施例1实时检测生物硫醇的比率型荧光探针的合成
采用新型固相光化学合成技术合成了氟硼二吡咯甲川(BODIPY)类荧光染料,该系列 染料对生物硫醇具有快速实时响应的优点,且为比率型荧光探针。该探针的合成路线图,如 附图1所示,醛基BODIPY的合成。具体包括如下:
1.中间染料氟硼二吡咯甲川-简(BOD-J)的合成和表征
BOD-J合成路线如图2所示,在氮气保护下,将苯甲酰氯(2.8g,0.02mol)和2,4-二甲 基吡咯(3.8g,0.04mol)用注射器加入到150mL氮气饱和的无水DCM的250mL圆底烧瓶中,用锡箔纸包住避光,室温搅拌过夜。随后将反应置于冰浴中,15min后缓慢滴加20mL 三乙胺和20mL三氟化硼乙醚,继续搅拌2h。待反应结束后,加入200mL水,剧烈震荡5min, 收集有机层,并将有机层用饱和食盐水和水依次洗涤三遍。随后用无水硫酸镁干燥有机层, 过滤后滤液经减压蒸馏除去多余的有机溶剂。所得粗产物用少量二氯甲烷溶解后经硅胶柱层析(石油醚/二氯甲烷为洗脱剂)梯度洗脱进行分离提纯,最后得到碧绿色粉末2.64g,产率:42%。
1H NMR(500MHz,CDCl3)δ7.50–7.46(m,3H),7.28(dd,J=7.4,2.0Hz,2H),5.98(s,2H), 2.56(s,6H),1.37(s,6H)。
2.染料氟硼二吡咯甲川-简双(BOD-JS)的合成和表征
BOD-JS合成路线如图3所示,向5mL无水N,N-二甲基甲酰胺(DMF)中加入染料BOD-J(97mg,0.3mmol)和3,5-二甲基苯甲醛(160mg,1.2mmol),除氧30min后,加入100μL 哌啶和100μL冰醋酸,室温搅拌5min后,置于微波反应器中,在150W功率下反应45min。 待反应结束后,将冷却的反应液倾入入50mL二氯甲烷中,并分别用饱和食盐水和水洗涤数 次。随后用无水硫酸镁干燥有机层,过滤后滤液经减压蒸馏除去多余的有机溶剂。所得粗产 物用少量二氯甲烷溶解后经硅胶柱层析(石油醚/二氯甲烷为洗脱剂)梯度洗脱进行分离提 纯,最后得到棕褐色粉末154mg,产率:93%。
1H NMR(500MHz,CDCl3)δ7.72(d,J=16.3Hz,2H),7.50(dd,J=4.8,2.3Hz,3H),7.32 (dd,J=7.2,2.1Hz,2H),7.26(s,4H),7.21(d,J=16.3Hz,2H),6.97(s,2H),6.63(s,2H),2.37(s, 12H),1.44(s,6H)。
3.中间体炔醛(QQ)的合成和表征
QQ合成路线如图4所示,往250mL无水丙酮中加入对羟基苯甲醛(6.1g,50mmol)和无水碳酸钾(9.7g,70mmol),加热回流30min,然后加入3-溴丙炔(11.1mL,100mmol), 继续加热回流反应2h。反应结束后减压蒸馏除去溶剂,将粗产品溶于水中并用乙酸乙酯(4×75mL)萃取,合并有机相,并用饱和食盐水和水洗涤数次。有机相在无水硫酸镁干燥后,过滤后滤液经减压蒸馏除去多余的有机溶剂。所得粗产物用少量二氯甲烷溶解后经硅胶柱层析 (石油醚/三氯甲烷为洗脱剂)梯度洗脱进行分离提纯,最后得到淡黄色粉末7.8g,产率:98%。
1H NMR(500MHz,CDCl3)δ9.91(s,1H),7.86(d,J=8.9Hz,2H),7.10(d,J=8.7Hz,2H), 4.79(d,J=2.4Hz,2H),2.57(s,1H)。
4.中间染料氟硼二吡咯甲川-炔(BOD-Q)的合成和表征
BOD-Q合成路线如图5所示,在氮气保护下,将QQ(1g,6.2mmol)溶于150mL氮 气饱和无水DCM,随后在氮气氛围中将2,4-二甲基吡咯(1.2g,12.6mmol)用注射器注入。 加入100μL三氟乙酸,溶液有无色变为棕红色,用锡箔纸包住反应体系避光,室温搅拌过夜。 加入DDQ(1.4g,6.2mmol)后继续避光室温搅拌45min。随后将反应置于冰浴中,15min 后缓慢滴加6mL三乙胺和6mL三氟化硼乙醚,继续搅拌2h。待反应结束后,加入200mL 水,剧烈震荡5min,收集有机层,并将有机层用饱和食盐水和水依次洗涤三遍。随后用无水 硫酸镁干燥有机层,过滤后滤液经减压蒸馏除去多余的有机溶剂。所得粗产物用少量二氯甲 烷溶解后经硅胶柱层析(石油醚/二氯甲烷为洗脱剂)梯度洗脱进行分离提纯,最后得到紫 红色粉末0.57g,产率:24%。
1H NMR(500MHz,CDCl3)δ7.20(d,J=8.7Hz,2H),7.09(d,J=8.8Hz,2H),5.97(s,2H), 4.76(d,J=2.4Hz,2H),2.55(s,7H),1.42(s,6H)。
5.染料氟硼二吡咯甲川-炔双(BOD-QS)的合成和表征
BOD-QS合成路线如图6所示,其合成方法及其参数条件与BOD-JS的合成相同,投入BOD-Q(113mg,0.3mmol),得到金黄色粉末BOD-QS 178mg,产率97%。
1H NMR(500MHz,CDCl3)δ7.71(d,J=16.3Hz,2H),7.25(s,3H),7.23(t,J=3.0Hz,2H), 7.19(s,1H),7.13–7.07(m,2H),6.96(s,2H),6.63(s,2H),4.78(d,J=2.4Hz,2H),2.57(s,1H), 2.37(s,12H),1.49(s,6H).
13C NMR(126MHz,CDCl3)δ158.15(s),152.77(s),142.08(s),138.56(s),138.26(s), 136.75(s),136.42(s),133.67(s),130.92(s),129.72(s),128.20(s),125.51(s),118.76(s),117.82 (s),115.59(s),78.10(s),75.93(s),56.07(s),21.29(s),14.85(s).
6.中间体溴醛(XQ)的合成与表征
XQ合成路线如图7所示,往40mL无水DMF中加入对羟基苯甲醛(2.44g,20mmol) 和无水碳酸钾(5.53g,40mmol),加热回流30min,然后加入1,2-二溴乙烷(7.43g,40mmol), 继续加热回流反应6h。反应结束后将反应液倾入冰水混合物中,过滤得到淡黄色粉末。将粉末重新溶解于二氯甲烷中,并经无水硫酸钠干燥,过滤干燥得到淡黄色产物1.26g,产率30%。
1H NMR(400MHz,CDCl3)δ9.92(s,1H),7.87(d,J=8.8Hz,2H),7.04(d,J=8.7Hz,2H), 4.40(t,J=6.2Hz,2H),3.69(t,J=6.2Hz,2H).
7.中间体叠醛(DQ)的合成和表征
DQ合成路线如图8所示,往40mL无水DMSO中加入DQ(1.26g,5.5mmol)和叠氮 化钠(0.45g,6.0mmol),加热回流2h。待反应结束并冷却后用二氯甲烷稀释,随后用饱和 食盐水和水将有机相洗涤数次,最后用无水硫酸钠干燥有机层。过滤后滤液经减压蒸馏除去 多余的有机溶剂。所得粗产物用少量二氯甲烷溶解后经硅胶柱层析(石油醚/乙酸乙酯为洗 脱剂)梯度洗脱进行分离提纯,最后得到淡黄色粉末0.82g,产率:80%。
1H NMR(500MHz,CDCl3)δ9.90(s,1H),7.93–7.73(m,2H),7.03(d,J=8.7Hz,2H),4.26 –4.20(m,2H),3.72–3.62(m,2H).
8.中间染料氟硼二吡咯甲川-叠(BOD-D)的合成和表征
BOD-D合成路线如图9所示,其合成方法及其参数条件与BOD-Q合成相同,投入DQ(1.9g,10mmol),得到亮黄色针状产物HOD-D818 mg,产率:20%。
1H NMR(500MHz,CDCl3)δ7.21–7.17(m,2H),7.06–7.01(m,2H),5.98(s,2H),4.23–4.18(m,2H),3.68–3.63(m,2H),2.55(s,6H),1.43(s,6H).
9.染料氟硼二吡咯甲川-叠双(BOD-DS)的合成和表征
BOD-DS合成路线如图10所示,其合成方法及其参数条件与BOD-JS合成相同,投入BOD-D(123mg,0.3mmol),得到金黄色粉末BOD-QS 188mg,产率98%。
1H NMR(500MHz,CDCl3)δ7.71(d,J=16.3Hz,2H),7.26–7.25(m,2H),7.24(s,1H),7.23(s,2H),7.20(s,1H),7.05(d,J=8.7Hz,2H),6.97(s,2H),6.63(s,2H),4.24–4.20(m,2H), 3.69–3.64(m,2H),2.37(s,12H),1.50(s,6H).
13C NMR(126MHz,CDCl3)δ158.82(s),152.75(s),142.11(s),138.63(s),138.29(s), 136.75(s),136.41(s),133.69(s),130.95(s),129.80(s),127.91(s),125.51(s),118.76(s),117.82 (s),115.12(s),66.98(s),50.25(s),21.29(s).
固相光化学合成α-甲酰化BODIPY衍生物
10.染料氟硼二吡咯甲川-简醛BOD-JQ的合成和表征
BOD-JQ合成路线如图11所示,将55.6mg染料BOD-JS溶解于10mL二氯甲烷中,然 后加入2g 200目硅胶,经减压旋转蒸发溶剂,并将混合物置于100W氙气灯下方10cm处光 照40min。可观察到混合物由墨绿色变为紫黑色。待混合物冷却至室温后,用二氯甲烷萃取 数次,合并有机相,经减压蒸馏除去多余有机溶剂,所得粗产物用少量二氯甲烷溶解后经硅胶柱层析(石油醚/三氯甲烷为洗脱剂)梯度洗脱进行分离提纯,最后得到淡黄色粉末31.3mg,产率:69%。BOD-JQ表征结果如图12-14所示:
理论分子量:454.20280,FT-MS:477.19202(M+Na+)。
1H NMR(500MHz,CDCl3)δ10.36(s,1H),7.73(d,J=16.3Hz,1H),7.57–7.52(m,3H),7.43(d,J=16.2Hz,1H),7.35–7.32(m,2H),7.28(s,2H),7.06(s,1H),6.81(d,J=8.8Hz,2H), 2.37(s,6H),1.52(s,3H),1.41(s,3H).
13C NMR(126MHz,CDCl3)δ184.46(s),161.08(s),148.14(s),143.48(s),143.22(s), 141.58(s),138.69(s),137.00(s),135.30(s),134.22(s),133.39(s),132.76(s),129.53(d,J=15.3 Hz),127.92(s),126.35(s),121.01(s),120.12(s),117.88(s),21.23(s),15.27(s),14.14(s).
11.染料氟硼二吡咯甲川-炔醛(BOD-QQ)的合成和表征
BOD-QQ合成路线如图15所示,其合成方法及其参数条件与BOD-JQ合成相同,投入BOD-QS(0.1mmol,61mg),得到产物37mg,产率72%。BOD-QQ表征结果如图16-18 所示:
理论分子量:508.21337,FT-MS:531.20259(M+Na+)。
1H NMR(500MHz,CDCl3)δ10.35(s,1H),7.73(d,J=16.1Hz,1H),7.44(d,J=16.2Hz, 1H),7.28(s,2H),7.24(s,2H),7.15(d,J=8.4Hz,2H),7.06(s,1H),6.81(d,J=9.1Hz,2H),4.79 (d,J=2.0Hz,2H),2.58(s,1H),2.37(s,6H),1.58(s,3H),1.47(s,3H).
13C NMR(126MHz,CDCl3)δ184.47(s),160.98(s),158.53(s),148.12(s),143.41(s), 143.19(s),141.42(s),138.69(s),136.96(s),135.30(s),132.74(s),129.28(s),127.14(s),126.34 (s),120.95(s),120.11(s),117.89(s),115.94(s),77.87(s),76.08(s),56.08(s),31.93(s),29.67(s), 29.37(s),22.70(s),21.23(s),15.49(s),14.36(s),14.13(s).
12.染料氟硼二吡咯甲川-叠醛(BOD-DQ)的合成和表征
BOD-DQ合成路线如图19所示,其合成方法及其参数条件与BOD-JQ合成相同,投入BOD-DS(0.1mmol,64mg),得到产物38mg,产率70%。BOD-DQ表征结果如图20-22 所示:
理论分子量:539.23041,FT-MS:562.21963(M+Na+)。
1H NMR(500MHz,CDCl3)δ10.35(s,1H),7.73(d,J=16.3Hz,1H),7.43(d,J=16.2Hz, 1H),7.28(s,2H),7.24(s,2H),7.11–7.07(m,2H),7.06(s,1H),6.81(d,J=9.2Hz,2H),4.26– 4.19(m,2H),3.71–3.64(m,2H),2.37(s,6H),1.58(s,3H),1.48(s,3H).
13C NMR(126MHz,CDCl3)δ184.47(s),161.00(s),159.24(s),148.11(s),143.43(s), 143.18(s),141.43(s),138.69(s),137.42(s),136.93(s),135.30(s),133.73(s),132.75(s),129.41 (s),126.93(s),126.34(s),120.97(s),120.09(s),117.88(s),115.43(s),67.05(s),50.22(s),31.94 (s),29.67(s),22.71(s),21.23(s),15.55(s),14.42(s),14.14(s).
细胞器靶向荧光染料合成
13.线粒体靶向氟硼二吡咯甲川-三苯基膦(BOD-PPh3)的合成
BOD-PPh3合成路线如图23所示,在氮气保护下,将BOD-QQ(50.8mg,0.1mmol) 和(4-叠氮丁基)三苯基溴化膦(43.9mg,0.1mmol)溶于混合溶剂中(14mL,CHCl3:EtOH:H2O =12:1:1,v/v),随后加入五水合硫酸铜(25mg,0.1mmol)和抗坏血酸钠(19.8mg,0.1mmol),用锡箔纸包住避光,室温搅拌反应24h。待反应结束后,加入200mL水,剧烈震荡5min, 用二氯甲烷萃取,收集有机层,并将有机层用饱和食盐水和水依次洗涤三遍。随后用无水硫 酸钠干燥有机层,过滤后滤液经减压蒸馏除去多余的有机溶剂。所得粗产物用少量二氯甲烷溶解后经硅胶柱层析(二氯甲烷/甲醇为洗脱剂)梯度洗脱进行分离提纯,最后得到碧绿色粉末37.9mg,产率:40%。BOD-PPh3表征结果如图24-26所示:
理论分子量:947.2947,FT-MS:868.3759(M–Br-)。
1H NMR(400MHz,DMSO-d6)δ10.19(s,1H),8.24(s,1H),7.97(d,J=16.3Hz,1H),7.91 (ddt,J=8.8,5.6,2.9Hz,3H),7.79(s,13H),7.58(s,1H),7.43(s,2H),7.33(s,2H),7.28(s,2H), 7.16(s,1H),6.87(s,1H),5.20(s,2H),4.49(s,2H),4.38(s,2H),2.36(s,6H),2.04(s,4H),1.58(s, 3H),1.45(s,3H).
13C NMR(101MHz,DMSO-d6)δ183.56,174.73,161.71,159.50,149.09,145.57,142.66, 142.08,139.03,137.66,136.45,135.55,135.44,135.41,134.09,133.99,133.79,133.36,130.79, 130.67,130.11,129.93,126.47,126.06,125.26,122.69,120.23,119.30,119.22,118.44,118.36, 117.11,116.04,61.71,56.48,55.39,49.87,48.61,35.58,31.75,30.85,30.67,29.55,29.49,29.33, 29.30,29.20,29.16,29.04,27.02,25.58,22.56,21.25,20.31,19.81,19.46,19.25,19.03,15.64, 14.42,14.29.
14.内质网靶向氟硼二吡咯甲川-氯(BOD-Cl)的合成
BOD-Cl合成路线如图27所示,在氮气保护下,将BOD-QQ(50.8mg,0.1mmol)和 1-叠氮-3-氯丙烷(11.9mg,0.1mmol)溶于混合溶剂中(10mL,DMSO:CH2Cl2=1:1,v/v), 随后加入五水合硫酸铜(25mg,0.1mmol)和抗坏血酸钠(19.8mg,0.1mmol),用锡箔纸 包住避光,室温搅拌反应24h。随后将反应置于冰浴中,15min后缓慢滴加20mL三乙胺和20mL三氟化硼乙醚,继续搅拌2h。待反应结束后,加入200mL水,剧烈震荡5min,用二 氯甲烷萃取,收集有机层,并将有机层用饱和食盐水和水依次洗涤三遍。随后用无水硫酸钠 干燥有机层,过滤后滤液经减压蒸馏除去多余的有机溶剂。所得粗产物用少量二氯甲烷溶解 后经硅胶柱层析(二氯甲烷/甲醇为洗脱剂)梯度洗脱进行分离提纯,最后得到碧绿色粉末 28.2mg,产率:45%。BOD-Cl表征结果如图28-30所示:
理论分子量:627.2384,FT-MS:650.2287(M+Na+)。
1H NMR(400MHz,CDCl3)δ10.35(s,1H),7.78–7.67(m,2H),7.43(d,J=16.2Hz,1H),7.27(s,2H),7.25–7.21(m,2H),7.16(d,J=8.4Hz,2H),7.06(s,1H),6.81(d,J=6.7Hz,2H), 5.28(s,2H),4.61(t,J=6.6Hz,2H),3.55(t,J=6.0Hz,2H),2.44(p,J=6.2Hz,2H),2.37(s,6H), 1.57(s,3H),1.46(s,3H).
13C NMR(101MHz,CDCl3)δ184.45,161.00,159.23,148.13,143.46,143.09,141.42, 138.67,137.41,136.84,135.28,133.74,132.74,129.35,126.81,126.33,123.60,120.98,120.09, 117.83,116.52,115.68,62.00,47.18,41.09,32.46,29.71,29.35,21.23,15.51,14.38.
实施例2探针性能及其应用——光谱测试用溶液的配置以及测试方法
以下实验如未特殊注明,皆以生物体内含量最多的GSH作为生物硫醇物质代表进行实验。
母液的配制方法:将探针分子BOD-JQ用四氢呋喃(THF)配置成10-3mol L-1的标准溶 液,放置于4℃备用。
1.pH影响的测定——pH选择
配置一系列浓度为0.2mol L-1的醋酸-醋酸钠缓冲溶液、磷酸氢二钠-磷酸二氢钠缓冲溶液、 磷酸氢二钾-磷酸二氢钾缓冲溶液(PBS)、硼酸-硼砂缓冲溶液以及碳酸氢钠-碳酸钠缓冲溶液。 然后分别将DMSO、水以及这些溶液按14:5:1体积进行混溶,然后取4mL该系列混合溶 剂,并各加入20μL母液,探针终浓度为5μM,测其荧光光谱,观察探针分子随着pH的变 化荧光光谱的变化。并分别测试加入100当量的GSH溶液后,观察探针分子与GSH反应产 物随着pH的变化荧光光谱的变化。
结果如图31所示,当pH在3.66~7.4范围时,探针分子在544nm处和596nm处荧光强度比值R0(I544nm/I596nm)基本保持不变。当pH值在7.4~11.01范围时,探针分子荧光强 度比值R0(I544nm/I596nm)先略微增强而后下降。当加入GSH后探针荧光强度比值R(I544nm /I596nm)在pH小于6.72的范围内基本不变,在pH在6.72~8.35之间,探针分子荧光强度比 值R0(I544nm/I596nm),随着pH的增大而增大。此后随着pH的升高其值基本保持不变。这些 结果表明,该探针对GSH的检测在偏碱性条件下最为有利。
如图32所示,在不同pH值下,探针对GSH检测的灵敏度(R/R0)在pH为7.4时其值 最大,故后续实验所用pH值皆为7.4。
2.BOD-JQ对GSH的荧光检测
取20μL母液溶于4mL DMSO:H2O:PBS(14:5:1,pH=7.4,浓度为0.2mol L-1), 探针终浓度为5μM。用移液枪逐渐加入一定体积的GSH溶液(控制最终加入浓度总体积<75 μL),混合均匀,立即扫相应的紫外-可见吸收光谱。(因为探针对GSH的响应时间极快,1s 以内即可反应完全)。荧光光谱图由类似方法扫得。
结果如图33中的浓度滴定曲线可以看出,在DMSO:H2O:PBS=14:5:1(PBS缓冲溶液浓度为0.2mol L-1,pH=7.4)的测试体系中(探针终浓度为5μM),随着GSH溶液的加 入,探针分子的最大吸收波长570nm处吸光度逐渐下降,并在519nm处生成一个新峰,溶 液颜色由粉红色变为橙黄色。与此同时探针在596nm处的荧光逐渐减弱,而在544nm处的 荧光则逐渐增强,在紫外灯的照射下,溶液由呈现出强烈的橙红色荧光变为黄绿色荧光。我 们做了I544nm/I596nm荧光强度比值与GSH浓度变化曲线,如图34所示。我们通过线性拟合 发现,加入GSH后,I544nm/I596nm荧光强度比值与GSH浓度在4~70μM之间呈非常好的线 性关系(R2=0.997),据此可以定量检测低浓度的GSH。
对没有加入GSH的探针BOD-JQ空白溶液(空白样)的荧光比值(I544nm/I596nm)进行 6次测试,计算出测量标准偏差为0.0057。则BOD-JQ的检测下限可以根据如下公式计算:
LOD=K×SD/S
其中K=3;SD为空白样的标准偏差;S为拟合曲线的斜率。
LOD=K×SD/S=3×0.0057/0.00961=1.8μM,也即检测下限LOD为1.8μM。一般而言细胞中谷胱甘肽的浓度为1~10mM,因此该探针可以满足一般生物体系中谷胱甘肽的检测要求。此外由图34可知,BOD-JQ对Cys和Hcy具有类似的响应效果,虽然细胞中Cys 和Hcy的浓度较低,一般为30~200μM和5~15μM。但探针BOD-JQ是检测生物体系中生 物硫醇总浓度的探针,一般而言三个常见生物硫醇物质的总浓度在mM级别,因此该探针的 灵敏度可满足一般生物体系中生物硫醇的检测需求。
3.选择性实验
在DMSO:H2O:PBS(14:5:1,pH=7.4,浓度为0.2mol L-1)的测试溶液中,探针分 子浓度为5μM,每个样品中分别加入100当量的AA,Ala,Arg,Glu,Gly,His,Leu,Phe, Trp,Val,Cys,Hcy和GSH,并测定荧光光谱前后的变化。
经荧光光谱仪测定了探针BOD-JQ对不同物质的荧光响应,我们选择了常见的氨基酸和 抗坏血酸来考察探针的选择性。实验结果从图35可以看出:相对于未加硫醇分子时的荧光光 谱,Cys,Hcy和GSH的加入带来了明显的荧光变化,而其他氨基酸和抗坏血酸的加入基本 不会对探针的荧光性能造成影响。这说明探针BOD-JQ对生物硫醇分子具有非常好的选择性。
4.干扰性实验
在DMSO:H2O:PBS(14:5:1,pH=7.4,浓度为0.2mol L-1)的测试溶液中,探针分 子浓度为5μM,每个样品中都加入100当量GSH溶液,并分别加入100当量的AA,Ala,Arg,Glu,Gly,His,Leu,Phe,Trp和Val,并测定荧光光谱前后的变化,考察探针在GSH 与其他物质共存时其荧光光谱响应情况。
为了进一步考察探针BOD-JQ对生物硫醇检测的干扰性,我们选择GSH为生物硫醇类物 质的代表,在其他不同物质共存的条件下测试了探针BOD-JQ对GSH的检测能力,其结果如 图38所示。从图36可以看出,其他物质共存时并不会明显影响探针BOD-JQ对GSH的响应, 因此,探针BOD-JQ作为生物硫醇分子的荧光探针在检测时具有较好的抗干扰能力。
5.BOD-JQ检测机理验证
通过对加入GSH溶液后体系光谱的变化情况对产物进行合理的推断,并通过高分辨质谱 对反应产物进行鉴定。
根据之前的荧光光谱滴定实验中体系荧光蓝移的现象,据此可以推断分子的共轭程度应 该有所减小。BOD-JQ上存在着一个芳香醛基,基于醛基可以构建硫醇类物质的荧光探针。 但基于醛基的硫醇类物质荧光探针能选择性的检测半胱氨酸/高半胱氨酸,而对谷胱甘肽则不 会有响应。这是因为巯基与醛基作用后邻近的氨基会继续与其作用,最后生成稳定的五(六) 元环,而谷胱甘肽的邻近位置则没有氨基,不能进行响应,其反应机理如图37所示。此外由 图38可知,三个硫醇分子与探针作用后,其荧光光谱几乎一致,因此应该是基于相同响应机 理。结合光谱实验我们推断该探针检测机理应该是基于巯基与BODIPY衍生物5-位苯乙烯基 上的烯烃发生迈克尔加成反应。有文献报道在探针有芳香醛和识别基团共存时,生物硫醇的 巯基仍可选择性地与识别基团的烯烃进行迈克尔加成或者还原二硫键而不与醛基发生作用。 由于该探针对巯基化合物的检测很灵敏,且探针与巯基作用后生成的产物可能较少等原因, 我们并没有得到质谱等更为直观的证据证明该机理。
以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之 内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之。
Claims (10)
2.权利要求1所述的探针的制备方法,包括如下步骤:
(1)第一染料、第二染料和第三染料的合成;
所述第一染料的结构式为:
所述第二染料的结构式为:
所述第三染料的结构式为:
(2)固相光化学合成α-甲酰化BODIPY衍生物;
(3)细胞器靶向荧光染料合成;
其中,所述步骤(1)的合成方法包括:向无水N,N-二甲基甲酰胺中加入第一中间染料、第二中间染料或第三中间染料,以及3,5-二甲基苯甲醛,除氧后,加入哌啶和冰醋酸,室温搅拌后,置于微波反应器中反应;待反应结束后,将冷却的反应液倾入二氯甲烷中,并分别用饱和食盐水和水洗涤数次,随后用无水硫酸镁干燥有机层,过滤后滤液经减压蒸馏除去多余的有机溶剂,所得粗产物用少量二氯甲烷溶解后经硅胶柱层析,梯度洗脱进行分离提纯,最后得到所述第一染料、所述第二染料或所述第三染料粉末;
所述第一中间染料的结构式为:
所述第二中间染料的结构式为:
所述第三中间染料的结构式为:
所述步骤(2)包括,第四染料、第五染料和/或第六染料的合成;
所述第四染料的结构式为:
所述第五染料的结构式为:
所述第六染料的结构式为:
所述步骤(3)中所述细胞器为线粒体或内质网。
3.根据权利要求2所述的方法,所述第四染料、所述第五染料或所述第六染料的合成方法包括:将所述第一染料、所述第二染料或所述第三染料溶解于二氯甲烷中,然后加入50-500目硅胶,经减压旋转蒸发溶剂,并将混合物置于氙气灯下方处光照,可观察到混合物由墨绿色变为紫黑色,待混合物冷却至室温后,用二氯甲烷萃取数次,合并有机相,经减压蒸馏除去多余有机溶剂,所得粗产物用少量二氯甲烷溶解后经硅胶柱层析,梯度洗脱进行分离提纯,最后得到粉末。
5.根据权利要求2所述的方法,所述细胞器靶向荧光染料合成步骤包括:
在氮气保护下,将所述第五染料以及(4-叠氮丁基)三苯基溴化膦溶于混合溶剂中,随后加入五水合硫酸铜和抗坏血酸钠,用锡箔纸包住避光,室温搅拌反应,待反应结束后,加入水,剧烈震荡,用二氯甲烷萃取,收集有机层,并将有机层用饱和食盐水和水依次洗涤数次,随后用无水硫酸钠干燥有机层,过滤后滤液经减压蒸馏除去多余的有机溶剂,所得粗产物用少量二氯甲烷溶解后经硅胶柱层析,梯度洗脱进行分离提纯,最后得到粉末;所述细胞器为线粒体。
6.根据权利要求2所述的方法,所述细胞器靶向荧光染料合成步骤包括:
在氮气保护下,将所述第五染料以及1-叠氮-3-氯丙烷溶于混合溶剂中,随后加入五水合硫酸铜和抗坏血酸钠,用锡箔纸包住避光,室温搅拌反应;待反应结束后,加入水,剧烈震荡,用二氯甲烷萃取,收集有机层,并将有机层用饱和食盐水和水依次洗涤数次;随后用无水硫酸钠干燥有机层,过滤后滤液经减压蒸馏除去多余的有机溶剂;所得粗产物用少量二氯甲烷溶解后经硅胶柱层析,梯度洗脱进行分离提纯,最后得到粉末。
7.权利要求1所述的探针在制备生物硫醇检测或细胞成像的试剂或试剂盒中的应用。
8.根据权利要求7所述的应用,所述生物硫醇检测是在偏碱性条件下进行。
9.根据权利要求8所述的应用,所述偏碱性条件的pH为7.2-8.0。
10.根据权利要求9所述的应用,所述偏碱性条件的pH为7.4。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911083391.7A CN110818732B (zh) | 2019-11-07 | 2019-11-07 | 基于bodipy的高效实时生物硫醇荧光检测探针 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911083391.7A CN110818732B (zh) | 2019-11-07 | 2019-11-07 | 基于bodipy的高效实时生物硫醇荧光检测探针 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110818732A CN110818732A (zh) | 2020-02-21 |
CN110818732B true CN110818732B (zh) | 2022-05-06 |
Family
ID=69553304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911083391.7A Active CN110818732B (zh) | 2019-11-07 | 2019-11-07 | 基于bodipy的高效实时生物硫醇荧光检测探针 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110818732B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113004311B (zh) * | 2021-02-05 | 2022-07-19 | 嘉兴学院 | 一种氟硼二吡咯类荧光探针、其制备方法及在金离子检测中的应用 |
CN115572304A (zh) * | 2021-06-21 | 2023-01-06 | 深圳先进技术研究院 | 一种可见光诱导bodipy光笼分子释放醛类化合物的反应体系和方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102532178A (zh) * | 2011-12-23 | 2012-07-04 | 浙江理工大学 | 一种检测生物巯基的荧光探针及其制备方法与使用方法 |
CN105906643A (zh) * | 2016-05-16 | 2016-08-31 | 湘潭大学 | 一种近红外gsh荧光探针的制备方法和应用 |
CN106432315A (zh) * | 2016-10-17 | 2017-02-22 | 湘潭大学 | 一种基于氟硼吡咯的Cys荧光探针的制备方法和应用 |
CN107721922A (zh) * | 2017-10-24 | 2018-02-23 | 贺州学院 | 一种新型喹啉类生物硫醇荧光探针及其制备和应用 |
-
2019
- 2019-11-07 CN CN201911083391.7A patent/CN110818732B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102532178A (zh) * | 2011-12-23 | 2012-07-04 | 浙江理工大学 | 一种检测生物巯基的荧光探针及其制备方法与使用方法 |
CN105906643A (zh) * | 2016-05-16 | 2016-08-31 | 湘潭大学 | 一种近红外gsh荧光探针的制备方法和应用 |
CN106432315A (zh) * | 2016-10-17 | 2017-02-22 | 湘潭大学 | 一种基于氟硼吡咯的Cys荧光探针的制备方法和应用 |
CN107721922A (zh) * | 2017-10-24 | 2018-02-23 | 贺州学院 | 一种新型喹啉类生物硫醇荧光探针及其制备和应用 |
Non-Patent Citations (3)
Title |
---|
BODIPY based realtime, reversible and targeted fluorescent probes for biothiol imaging in living cells;Rongkun He等;《Chem. Commun.》;20201103;第56卷;14717-14720 * |
STN检索报告;ACS;《STN Registry》;20170831;1-4 * |
Tracking HOCl concentrations across cellular organelles in real time using a super resolution microscopy probe;Firoj Ali等;《Chem. Commun》;20180131;第54卷;1849-1852 * |
Also Published As
Publication number | Publication date |
---|---|
CN110818732A (zh) | 2020-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chen et al. | A two-photon ESIPT based fluorescence probe for specific detection of hypochlorite | |
Li et al. | A novel solvent-dependently bifunctional NIR absorptive and fluorescent ratiometric probe for detecting Fe3+/Cu2+ and its application in bioimaging | |
Ge et al. | A novel imidazo [1, 5-a] pyridine-rhodamine FRET system as an efficient ratiometric fluorescent probe for Hg2+ in living cells | |
Shen et al. | Building Rhodamine-BODIPY fluorescent platform using Click reaction: Naked-eye visible and multi-channel chemodosimeter for detection of Fe3+ and Hg2+ | |
Ge et al. | Detection of Hg2+ by a FRET ratiometric fluorescent probe based on a novel pyrido [1, 2-a] benzimidazole-rhodamine system | |
Fu et al. | A novel fluorescent-colorimetric probe for Al 3+ and Zn 2+ ion detection with different response and applications in F− detection and cell imaging | |
Huang et al. | Revealing aggregation-induced emission effect of imidazolium derivatives and application for detection of Hg2+ | |
Bhalla et al. | Rhodamine appended terphenyl: A reversible “off–on” fluorescent chemosensor for mercury ions | |
Du et al. | A near-infrared fluorescent probe for selective and quantitative detection of fluoride ions based on Si-Rhodamine | |
CN108690032B (zh) | 一种吩嗪稠合结构的荧光染料及其合成方法 | |
Yang et al. | BODIPY-based fluorescent probe for cysteine detection and its applications in food analysis, test strips and biological imaging | |
Liu et al. | A lysosome-targeting viscosity-sensitive fluorescent probe based on a novel functionalised near-infrared xanthene-indolium dye and its application in living cells | |
Kursunlu et al. | A highly branched macrocycle-based dual-channel sensor: Bodipy and pillar [5] arene combination for detection of Sn (II) &Hg (II) and bioimaging in living cells | |
CN110818732B (zh) | 基于bodipy的高效实时生物硫醇荧光检测探针 | |
CN113501818B (zh) | 一种荧光探针分子及其制备方法与应用 | |
Liu et al. | A squaraine-based red emission off–on chemosensor for biothiols and its application in living cells imaging | |
Jiang et al. | A novel chemosensor for the distinguishable detections of Cu2+ and Hg2+ by off–on fluorescence and ratiometric UV–visible absorption | |
CN113121520B (zh) | 一种具有aie+esipt+ict机制的荧光染料和荧光探针及其制备方法与应用 | |
Xue et al. | Ratiometric fluorescent sensors for detecting zinc ions in aqueous solution and living cells with two-photon microscopy | |
Wu et al. | A highly selective visible light excitable boron dipyrromethene probe for cysteine over homocysteine and glutathione based on a Michael addition reaction | |
Zeng et al. | A near-infrared fluorescent sensor with large Stokes shift for rapid and highly selective detection of thiophenols in water samples and living cells | |
Yang et al. | A novel xanthylene-based effective mitochondria-targeting ratiometric cysteine probe and its bioimaging in living cells | |
Qu et al. | A highly selective NIR fluorescent turn-on probe for hydroxyl radical and its application in living cell images | |
CN110526908B (zh) | 基于2-苯乙烯基吲哚盐类衍生物长波发射可区分检测Cys/Hcy荧光探针及其应用 | |
Chan et al. | An imidazole-based fluorescent probe for the Mercury (II) Ion with rapid response in vitro |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |